Fortress Diagnostics Limited of Antrim, Northern Ireland at MEDICA 2020 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

Fortress Diagnostics Limited

Antrim Technology Park Belfast Rd., BT41 1QS Antrim, Northern Ireland
United Kingdom of Great Britain and Northern Ireland
Telephone +44 28 94487676
Fax +44 28 94469933
info@fortressdiagnostics.com

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

Media files

Contact

Dr Morteza Afrasiabi

Managing Director

Phone
02894487676

Email
marketing@fortressdiagnostics.com

Mervyn Russell

Export Development Manager

Phone
02894487676

Email
mervyn@fortressdiagnostics.com

Gerard O'Neill

Sales Manager

Phone
02894487676

Email
gerard@fortressdiagnostics.com

Rosita Zolnourian

Operations Director

Phone
02894487676

Email
marketing@fortressdiagnostics.com

Visit us

Unsettled / NN

16.11.2020

Topic

10:00 - 16:00

1-1 Consultations

Throughout Virtual Medica 2020 the Fortress team will be available to book 1-1 consultations to discuss your  IVD requirments and business solutions for the year ahead. 
 
Arrange a meeting: 
Connect with Mervyn or Gerard, Morteza or Rosita via Medica Matchmaking or at marketing@fortressdiagnostics.com to arrange a meeting.

More Less

17.11.2020

Topic

10:00 - 16:00

1-1 Consultations

Throughout Virtual Medica 2020 the Fortress team will be available to book 1-1 consultations to discuss your  IVD requirments and business solutions for the year ahead. 
 
Arrange a meeting: 
Connect with Mervyn or Gerard, Morteza or Rosita via Medica Matchmaking or at marketing@fortressdiagnostics.com to arrange a meeting.

More Less

18.11.2020

Topic

10:00 - 16:00

1-1 Consultations

Throughout Virtual Medica 2020 the Fortress team will be available to book 1-1 consultations to discuss your  IVD requirments and business solutions for the year ahead. 
 
Arrange a meeting: 
Connect with Mervyn or Gerard, Morteza or Rosita via Medica Matchmaking or at marketing@fortressdiagnostics.com to arrange a meeting.

More Less

19.11.2020

Topic

10:00 - 16:00

1-1 Consultations

Throughout Virtual Medica 2020 the Fortress team will be available to book 1-1 consultations to discuss your  IVD requirments and business solutions for the year ahead. 
 
Arrange a meeting: 
Connect with Mervyn or Gerard, Morteza or Rosita via Medica Matchmaking or at marketing@fortressdiagnostics.com to arrange a meeting.

More Less

Our range of products

Product categories

  • 03  Diagnostic tests
  • 03.01  Clinical chemistry
  • 03.01.04  Rapid tests in clinical chemistry
  • 03  Diagnostic tests
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.02  Diagnostic rapid tests
  • 03  Diagnostic tests
  • 03.07  Other diagnostics

Our products

Product category: Rapid tests in clinical chemistry, Diagnostic rapid tests

Fortress Diagnostics Covid-19 Testing

Fortress Diagnostics research and development team have been working tirelessly on developing testing kits to detect the coronavirus.

To date they have developed the following state of the art kits:

  • Fortress Fast Rapid Antigen
  • Fortress Fast IGG/IgM Rapid Device 
  • Total Anti Body Elisa
  • RT-PCR (universal mini kit)
As we learn more on the virus Fortress R&D team are working round the clock on the following additional tests.

More Less

Product category: Rapid tests in clinical chemistry

Fortress Diagnostics Clinical Chemistry Reagents

Fortress Diagnostics manufacturers, develops and supplies an extensive range of high quality clinical chemistry reagents.

Our reagents are manufactured to the highest quality standards in an ISO 13485:2016–certified laboratory, ensuring excellent stability, accuracy and results you can trust.

Benefits of Fortress Diagnostics' reagents:
  • Variety of sizes available to ensure cost efficiency for any laboratory size.
  • Excellent stability.
  • Variety of methods available.
  • Extensive and every growing portfolio of bar coded and non-bar coded reagents for use on a range of analysers.
  • Full range of controls and calibrators also available.

More Less

Product category: Diagnostic rapid tests

Fortress Diagnostics Rapid Tests

Rapid Diagnostic Tests
Fortress Diagnostics offers a range of rapid diagnostic tests (RDTs) suitable for preliminary or emergency medical screening for use in medical facilities with limited resources and laboratories with low number of tests per day. 

Key Features:

High quality & easy-to-use. 
Quick results  – 10 minutes to 2 hours – providing timely treatment interventions.
Little or no additional equipment required.
More economical than ELISAs in low throughput laboratories.
Possibility to store at room temperature for extended length of time.
 

More Less

Product category: Other diagnostics

Fortress Diagnostics Immunoassays ELISA

The enzyme-linked immunosorbent assay (ELISA) is an immunological assay commonly used to measure antibodies, antigens, proteins and glycoproteins in biological samples. Some examples include: diagnosis of HIV infection, pregnancy tests, and measurement of cytokines or soluble receptors in cell supernatant or serum. ELISA assays are generally carried out in 96 well plates, allowing multiple samples to be measured in a single experiment. These plates need to be special absorbant plates (e.g. NUNC Immuno plates) to ensure the antibody or antigen sticks to the surface. Each ELISA measures a specific antigen, and kits for a variety of antigens are widely available. Cost Efficient

More Less

Product category: Rapid tests in clinical chemistry

Fortress Diagnostics Controls & Calibrators

Fortress Diagnostics' quality control range Seraqual is utilised in laboratories across the world to enable laboratories to confidently produce accurate results.

Our Seraqual controls & calibrators are designed and manufactured in-house to the highest quality standards.  Kits are supplied with methodology and instrumentation related comparisons and used in many EQA programs worldwide including our own F)QAS and partnering EQA provider ESfEQA.

Why choose Seraqual quality controls?

  • Manufactured in house we have full control and traceability.
  • Extensive and ever growing range available.
  • Custom quality control service available.
  • Highly compatible, designed to mimic human samples with minimal matrix effects being observed.
  • Offer a wide parameter range allowing more analyte coverage single control.
  • Use the search bar below to view Fortress Diagnostics' range of Seraqual quality controls and calibrators and click here to find out more about our EQA programs. 

More Less

Company news

Date

Topic

Download

Nov 10, 2020

Imperial College London Select Fortress Fast Antibody Home Test as most promising kit.

More Less

Aug 13, 2020

Fortress Fast Preferred Test

More than 100,000 people across England have tested themselves for SARS-CoV-2 antibodies at home using the fortress fast as part of a major research programme.

Led by Imperial College London, the REACT (REal Time Assessment of Community Transmission) study is using fortress fast antibody finger-prick tests to track past infections and monitor the progress of the pandemic. It’s the first nation-wide antibody surveillance study to be rolled out across England using self-testing at home.

The research involved almost 300 healthy volunteers, all NHS staff or close family members, who had a previous diagnosis of COVID-19 confirmed by lab tests. None of them had serious symptoms at the time of infection, nor had they been hospitalised due to the disease, and it had been at least 21 days since the onset of symptoms. Analysing test performance on individuals who have had mild cases is essential to understand their potential for widespread use in the community.

The volunteers first carried out the tests themselves using instructions provided by each manufacturer, followed by a trained technician. Blood samples were also taken for comparison with gold-standard ELISA testing and another similar laboratory technique called RBD-DABA. This enabled the researchers to work out how ‘sensitive’ the tests are, meaning how well they correctly identify individuals who do have coronavirus antibodies – so-called ‘true positives’.

In addition to evaluating how accurate the tests are, further REACT studies have carried out a major public engagement exercise and national usability study to assess how easily people can use them at home without supervision. Feedback from a pilot user testing study involving 315 people was used to guide the design of the testing pack, an instruction manual and how-to video for the test.

More Less

About us

Company details

Our Objective
"The objective of Fortress Diagnostics is to provide the highest level of diagnostic solutions, globally, through continued investment in research and development"
Morteza Afrasiabi, Managing Director, Fortress Diagnostics
 
Our Company
Fortress Diagnostics is a multi award-winning global provider of in vitro diagnostics (IVDs). We develop, manufacture and support an extensive portfolio of clinical diagnostic tests from our ISO 13485:2016-accredited facility in the United Kingdom.
Through our global distribution network we provide highly accurate medical testing solutions to immunology, haematology and serological laboratories in hospitals, medical centres, clinics, blood banks and research institutions in over 100 international markets.

Our Certification
Our ISO 13485:2016 certification for the design, development, manufacturing and distribution of in vitro diagnostics medical reagents and instrumentation endorses our product range and ensures that the highest quality standards are constantly maintained.

Our Commitment
Fortress Diagnostics is fully committed to the advancement of the diagnostic industry. We reinvest a staggering 30% of turnover into Research and Development each year and employ a highly-skilled team of research scientists to innovate new and optimise existing products to ensure that the diagnostic tests we produce are at the forefront of technology.

More Less

Company data

Export content

> 75%

Number of employees

20-49

Foundation

1111

Area of business

Diagnostics

Company information as a PDF file